The rapport between anti diabetic medications,glycemic control in conjunction with risk of dementia in patients with Type II Diabetes Mellitus
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 138
- 试验地点
- 1
- 主要终点
- The study will determine risk of dementia in the age groups greater than 18 years of type 2 diabetic patients
研究概览
简要总结
INTRODUCTION
Diabetes is a leading global health crisis, significantly contributing to the prevalence of dementia, particularly through it’s impact on heart health and stroke risk, which are closely linked to cognitive decline.
OBJECTIVES
-
To identify the risk of occurrence of dementia in diabetic patients.
-
To determine the predictors for the risk of dementia among diabetic patients.
-
To analyze the rapport between anti-diabetic medication, glycemic control in conjunction with dementia risk in diabetic patient
METHODOLOGY
A cross-sectional observational study will be conducted for a duration of six months among 138 participants. Who are diagnosed with T2DM aged>18 years and stable will be included. Dementia risk will be evaluated using the MoCA assessment scale at Department of General Medicine of Justice K S Hegde Charitable Hospital
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 85.00 Year(s)（—）
入选标准
- •Patients who are diagnosed with type-2 diabetes and are on antidiabetic medication Age above 18 years Gender.
- •male and female Stable diabetic patients.
排除标准
- •Patients with known case of dementia.
- •Breast feeding and pregnant women Patients diagnosed with type 1 diabetes Patients who are already on dementia medications.
- •Patients on Vit B12 supplements.
结局指标
主要结局
The study will determine risk of dementia in the age groups greater than 18 years of type 2 diabetic patients
时间窗: single point
次要结局
- The study will analyse the relationship between anti-diabetic medication and glycaemic control with risk of dementia in type 2 DM.(Single point.)
研究者
Fathima zuhara banu
NGSM Institute of Pharmaceutical Sciences,